Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10

Journal of Neuroimmunology

Volumn 179, Issue 1-2, 2006, Pages 46-52

  Wuest, Todd ^a   Austin, Bobbie Ann ^a   Uematsu, Satoshi ^b   Thapa, Manoj ^a   Akira, Shizuo ^b   Carr, Daniel J J ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Chemokines; CXCL10; Herpes Simplex Virus 1; Toll like receptor 9; Type I interferon receptor

Indexed keywords

CXCL9 CHEMOKINE; DEOXYCYTIDINE PHOSPHATE; DEOXYCYTIDYLATE PHOSPHATE DEOXYGUANYLATE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORNEA; CORRELATION FUNCTION; FEMALE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; MALE; MOUSE; MOUSE STRAIN; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; VERO CELL; VIRUS REPLICATION; VIRUS SHEDDING; WILD TYPE;

ANIMALS; CERCOPITHECUS AETHIOPS; CHEMOKINE CXCL10; CHEMOKINE CXCL9; CHEMOKINES, CXC; FEMALE; HERPESVIRUS 1, HUMAN; INTERFERON TYPE I; KERATITIS, HERPETIC; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9; VERO CELLS;

EID: 33748957516     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.06.020     Document Type: Article

References (19)

1. Ashkar A.A., Bauer S., Mitchell W.J., Vieira J., and Rosenthal K.L. Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J. Virol. 77 (2003) 8948-8956
2. Ashkar A.A., Yao X.D., Gill N., Sajic D., Patrick A.J., and Rosenthal K.L. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J. Infect. Dis. 190 (2004) 1841-1849
3. Bhattacharjee R.N., and Akira S. Toll-like receptor signaling: emerging opportunities in human diseases and medicine. Curr. Immunol. Rev. 1 (2005) 81-90
4. Bonizzi G., and Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25 (2004) 280-288
5. Carr D.J., Chodosh J., Ash J., and Lane T.E. Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J. Virol. 77 (2003) 10037-10046
6. Carr D.J., Ash J., Lane T.E., and Kuziel W.A. Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1. J. Gen. Virol. 87 (2006) 489-499
7. Carr D.J., and Tomanek L. Herpes simplex virus and the chemokines that mediate the inflammation. Curr. Top. Microbiol. Immunol. 303 (2006) 47-65
8. Garvey T.L., Dyer K.D., Ellis J.A., Bonville C.A., Foster B., Prussin C., Easton A.J., Domachowske J.B., and Rosenberg H.F. Inflammatory responses to pneumovirus infection in IFN-αβR gene-deleted mice. J. Immunol. 175 (2005) 4735-4744
9. Härle P., Cull V., Agbaga M.-P., Silverman R., Williams B.R.G., James C., and Carr D.J.J. Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication. J. Virol. 76 (2002) 6558-6567
10. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
11. Hochrein H., Schlatter B., O'Keeffe M., Wagner C., Schmitz F., Schiemann M., Bauer S., Suter M., and Wagner H. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and-independent pathways. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11416-11421
12. Johnson A.C., Heinzel F.P., Diaconu E., Sun Y., Hise A.G., Golenbock D., Lass J.H., and Pearlman E. Activation of Toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation. Invest. Ophthalmol. Visual Sci. 46 (2005) 589-595
13. Kawai T., and Akira S. Innate immune recognition of viral infection. Nat. Immunol. 7 (2006) 131-137
14. Krug A., Luker G.D., Barchet W., Leib D.A., Akira S., and Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through Toll-like receptor 9. Blood 103 (2004) 1433-1437
15. Kumar A., Zhang J., and Yu F.-S.X. Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells. Immunology 117 (2005) 11-21
16. McCluskie M.J., Cartier J.L., Patrick A.J., Sajic D., Weeratna R.D., Rosenthal K.L., and Davis H.L. Treatment of intravaginal HSV-2 infection in mice: a comparison of CpG oligodoxynucleotides and resiquimod (R-848). Antiviral Res. 69 (2006) 77-85
17. Millhouse S., and Wigdahl B. Molecular circuitry regulating herpes simplex virus type 1 latency in neurons. J. Neurovirology 6 (2000) 6-24
18. Rodahl E., and Haarr L. A herpes simplex virus type 1 vector as marker for retrograde neuronal tracing: characterization of lacZ transcription and localization of labelled neuronal cells in sensory and autonomic ganglia after inoculation of the anterior segment of the eye. Exp. Eye Res. 71 (2000) 495-501
19. Valyi-Nagy T., Deshmane S., Dillner A., and Fraser N.W. Induction of cellular transcription factors in trigeminal ganglia of mice by corneal scarification, herpes simplex virus type 1 infection, and explantation of trigeminal ganglia. J. Virol. 65 (1991) 4142-4152